Peyronie's supportPeyronie's Disease Canada

Clinical studies

Peyronie's Clinical Studies

What the research actually shows for each Peyronie's treatment, in plain language.

In this section

Evidence summaries

These study pages show why the site weighs some recommendations more strongly than others. Stronger evidence gets stronger language; thinner evidence stays cautious.

Clinical Studies

RestoreX Clinical Studies

A plain-language summary of the RestoreX evidence used to support traction therapy content on this site.

  • Device-specific, peer-reviewed studies are central here.
  • The current source set includes a randomized trial plus follow-up data.
Clinical Studies

Vacuum Therapy Clinical Studies

A plain-language summary of the current VED evidence set used in this site's Peyronie's treatment pages.

  • Supportive evidence exists, but it is thinner and less definitive.
  • This page is designed to set expectations honestly.
Clinical Studies

Injection Therapy Studies

A high-level evidence page for injection therapy so treatment comparison pages can link to a dedicated study-focused summary.

  • Injections are part of the treatment evidence landscape.
  • This section supports balanced comparison rather than store routing.
Clinical Studies

Surgical Outcome Studies

A supporting evidence page that helps patients understand where surgery outcomes belong in the treatment conversation.

  • Surgical outcome data belong in context, not in isolation.
  • Stable disease and functional goals still frame the decision.
Clinical Studies

Guidelines and Evidence Hierarchy

See how this site weighs clinical guidelines, randomized trials, and smaller supportive studies when it writes treatment content.

  • Guidelines anchor the treatment map.
  • Device-specific trial evidence gets more weight than broad marketing claims.

The evidence tier framework

Every study page on this site assigns evidence strength by outcome, not by treatment category as a whole.

  • Clinical guidelines (AUA, EAU)

    Anchor the treatment framework: highest confidence for general landscape framing

    Strong

  • RestoreX for curvature and length

    Device-specific randomized trial: justifies stronger educational language

    Strong

  • Injection therapy

    Guideline-recognized non-surgical option: language stays measured

    Moderate

  • Surgical approaches

    Guideline-supported for chronic stable disease: specialist decision

    Moderate

  • VED: structural outcomes

    Thinner evidence for curvature and length goals: cautious language used

    Limited